APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA and Gene Cloning Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DNA and Gene Cloning Services Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchDNA and Gene Cloning Services Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA and Gene Cloning Services Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal DNA and Gene Cloning Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA and Gene Cloning Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA and Gene Cloning Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global DNA and Gene Cloning Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of DNA and Gene Cloning Services include Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome and Sino Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for DNA and Gene Cloning Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA and Gene Cloning Services, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA and Gene Cloning Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA and Gene Cloning Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA and Gene Cloning Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA and Gene Cloning Services revenue, projected growth trends, production technology, application and end-user industry.

DNA and Gene Cloning Services Segment by Company

Aragen Life Sciences

Bio-Techne

Charles River Laboratories

Curia

Eurofins

GenScript

Integrated DNA Technologies

MedGenome

Sino Biological

Syngene

Twist Bioscience

DNA and Gene Cloning Services Segment by Type

Gene Synthesis

Custom Cloning

Sub-cloning

Others

DNA and Gene Cloning Services Segment by Application

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Others

DNA and Gene Cloning Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA and Gene Cloning Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA and Gene Cloning Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA and Gene Cloning Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of DNA and Gene Cloning Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of DNA and Gene Cloning Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA and Gene Cloning Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA and Gene Cloning Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Synthesis Major Player Table 3. Custom Cloning Major Player Table 4. Sub-cloning Major Player Table 5. Others Major Player Table 6. Global DNA and Gene Cloning Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Academic & Research Institutes Major Player Table 8. Pharmaceutical & Biotechnology Companies Major Player Table 9. Others Major Player Table 10. DNA and Gene Cloning Services Industry Trends Table 11. DNA and Gene Cloning Services Industry Drivers Table 12. DNA and Gene Cloning Services Industry Opportunities and Challenges Table 13. DNA and Gene Cloning Services Industry Restraints Table 14. Global DNA and Gene Cloning Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global DNA and Gene Cloning Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global DNA and Gene Cloning Services Market Share by Region (2021-2026) Table 17. Global DNA and Gene Cloning Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global DNA and Gene Cloning Services Market Share by Region (2027-2032) Table 19. Global DNA and Gene Cloning Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global DNA and Gene Cloning Services Revenue Market Share by Players (2021-2026) Table 21. Global DNA and Gene Cloning Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global DNA and Gene Cloning Services Key Players Headquarters & Area Served Table 23. Global DNA and Gene Cloning Services Players, Product Type & Application Table 24. Global DNA and Gene Cloning Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global DNA and Gene Cloning Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global DNA and Gene Cloning Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global DNA and Gene Cloning Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global DNA and Gene Cloning Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global DNA and Gene Cloning Services Revenue Market Share by Type (2021-2026) Table 31. Global DNA and Gene Cloning Services Revenue Market Share by Type (2027-2032) Table 32. Global DNA and Gene Cloning Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global DNA and Gene Cloning Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global DNA and Gene Cloning Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global DNA and Gene Cloning Services Revenue Market Share by Application (2021-2026) Table 36. Global DNA and Gene Cloning Services Revenue Market Share by Application (2027-2032) Table 37. Aragen Life Sciences Company Information Table 38. Aragen Life Sciences Business Overview Table 39. Aragen Life Sciences DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Aragen Life Sciences DNA and Gene Cloning Services Product Portfolio Table 41. Aragen Life Sciences Recent Development Table 42. Bio-Techne Company Information Table 43. Bio-Techne Business Overview Table 44. Bio-Techne DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bio-Techne DNA and Gene Cloning Services Product Portfolio Table 46. Bio-Techne Recent Development Table 47. Charles River Laboratories Company Information Table 48. Charles River Laboratories Business Overview Table 49. Charles River Laboratories DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Charles River Laboratories DNA and Gene Cloning Services Product Portfolio Table 51. Charles River Laboratories Recent Development Table 52. Curia Company Information Table 53. Curia Business Overview Table 54. Curia DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Curia DNA and Gene Cloning Services Product Portfolio Table 56. Curia Recent Development Table 57. Eurofins Company Information Table 58. Eurofins Business Overview Table 59. Eurofins DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eurofins DNA and Gene Cloning Services Product Portfolio Table 61. Eurofins Recent Development Table 62. GenScript Company Information Table 63. GenScript Business Overview Table 64. GenScript DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. GenScript DNA and Gene Cloning Services Product Portfolio Table 66. GenScript Recent Development Table 67. Integrated DNA Technologies Company Information Table 68. Integrated DNA Technologies Business Overview Table 69. Integrated DNA Technologies DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Integrated DNA Technologies DNA and Gene Cloning Services Product Portfolio Table 71. Integrated DNA Technologies Recent Development Table 72. MedGenome Company Information Table 73. MedGenome Business Overview Table 74. MedGenome DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. MedGenome DNA and Gene Cloning Services Product Portfolio Table 76. MedGenome Recent Development Table 77. Sino Biological Company Information Table 78. Sino Biological Business Overview Table 79. Sino Biological DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sino Biological DNA and Gene Cloning Services Product Portfolio Table 81. Sino Biological Recent Development Table 82. Syngene Company Information Table 83. Syngene Business Overview Table 84. Syngene DNA and Gene Cloning Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Syngene DNA and Gene Cloning Services Product Portfolio Table 86. Syngene Recent Development Table 87. Twist Bioscience Company Information Table 88. Twist Bioscience Business Overview Table 89. Twist Bioscience DNA and Gene Cloning Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Twist Bioscience DNA and Gene Cloning Services Product Portfolio Table 91. Twist Bioscience Recent Development Table 92. North America DNA and Gene Cloning Services Revenue by Type (2021-2026) & (US$ Million) Table 93. North America DNA and Gene Cloning Services Revenue by Type (2027-2032) & (US$ Million) Table 94. North America DNA and Gene Cloning Services Revenue by Application (2021-2026) & (US$ Million) Table 95. North America DNA and Gene Cloning Services Revenue by Application (2027-2032) & (US$ Million) Table 96. North America DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America DNA and Gene Cloning Services Revenue by Country (2021-2026) & (US$ Million) Table 98. North America DNA and Gene Cloning Services Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe DNA and Gene Cloning Services Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe DNA and Gene Cloning Services Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe DNA and Gene Cloning Services Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe DNA and Gene Cloning Services Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe DNA and Gene Cloning Services Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe DNA and Gene Cloning Services Revenue by Country (US$ Million) & (2027-2032) Table 106. China DNA and Gene Cloning Services Revenue by Type (2021-2026) & (US$ Million) Table 107. China DNA and Gene Cloning Services Revenue by Type (2027-2032) & (US$ Million) Table 108. China DNA and Gene Cloning Services Revenue by Application (2021-2026) & (US$ Million) Table 109. China DNA and Gene Cloning Services Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia DNA and Gene Cloning Services Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia DNA and Gene Cloning Services Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia DNA and Gene Cloning Services Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia DNA and Gene Cloning Services Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia DNA and Gene Cloning Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia DNA and Gene Cloning Services Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia DNA and Gene Cloning Services Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA DNA and Gene Cloning Services Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA DNA and Gene Cloning Services Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA DNA and Gene Cloning Services Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA DNA and Gene Cloning Services Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA DNA and Gene Cloning Services Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA DNA and Gene Cloning Services Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. DNA and Gene Cloning Services Image Figure 2. Global DNA and Gene Cloning Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA and Gene Cloning Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Synthesis Image Figure 5. Custom Cloning Image Figure 6. Sub-cloning Image Figure 7. Others Image Figure 8. Global DNA and Gene Cloning Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global DNA and Gene Cloning Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Academic & Research Institutes Image Figure 11. Pharmaceutical & Biotechnology Companies Image Figure 12. Others Image Figure 13. Global DNA and Gene Cloning Services Market Size (US$ Million) & (2021-2032) Figure 14. Global DNA and Gene Cloning Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global DNA and Gene Cloning Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global DNA and Gene Cloning Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global DNA and Gene Cloning Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global DNA and Gene Cloning Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global DNA and Gene Cloning Services Revenue Market Share by Type (2021-2032) Figure 21. Global DNA and Gene Cloning Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global DNA and Gene Cloning Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global DNA and Gene Cloning Services Revenue Market Share by Application (2021-2032) Figure 24. North America DNA and Gene Cloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America DNA and Gene Cloning Services Revenue Share by Type (2021-2032) Figure 26. North America DNA and Gene Cloning Services Revenue Share by Application (2021-2032) Figure 27. North America DNA and Gene Cloning Services Revenue Share by Country (2021-2032) Figure 28. United States DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe DNA and Gene Cloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe DNA and Gene Cloning Services Revenue Share by Type (2021-2032) Figure 33. Europe DNA and Gene Cloning Services Revenue Share by Application (2021-2032) Figure 34. Europe DNA and Gene Cloning Services Revenue Share by Country (2021-2032) Figure 35. Germany DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China DNA and Gene Cloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China DNA and Gene Cloning Services Revenue Share by Type (2021-2032) Figure 45. China DNA and Gene Cloning Services Revenue Share by Application (2021-2032) Figure 46. Asia DNA and Gene Cloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia DNA and Gene Cloning Services Revenue Share by Type (2021-2032) Figure 48. Asia DNA and Gene Cloning Services Revenue Share by Application (2021-2032) Figure 49. Asia DNA and Gene Cloning Services Revenue Share by Region (2021-2032) Figure 50. Japan DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA DNA and Gene Cloning Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA DNA and Gene Cloning Services Revenue Share by Type (2021-2032) Figure 58. SAMEA DNA and Gene Cloning Services Revenue Share by Application (2021-2032) Figure 59. SAMEA DNA and Gene Cloning Services Revenue Share by Country (2021-2032) Figure 60. Brazil DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt DNA and Gene Cloning Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Synthesis
  • Custom Cloning
  • Sub-cloning
  • Others
Applications
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
Companies covered
  • Aragen Life Sciences
  • Bio-Techne
  • Charles River Laboratories
  • Curia
  • Eurofins
  • GenScript
  • Integrated DNA Technologies
  • MedGenome
  • Sino Biological
  • Syngene
  • Twist Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA and Gene Cloning Services Market by Type
  3. 1.2.1 Global DNA and Gene Cloning Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Synthesis
  5. 1.2.3 Custom Cloning
  6. 1.2.4 Sub-cloning
  7. 1.2.5 Others
  8. 1.3 DNA and Gene Cloning Services Market by Application
  9. 1.3.1 Global DNA and Gene Cloning Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Academic & Research Institutes
  11. 1.3.3 Pharmaceutical & Biotechnology Companies
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 DNA and Gene Cloning Services Market Dynamics
  1. 2.1 DNA and Gene Cloning Services Industry Trends
  2. 2.2 DNA and Gene Cloning Services Industry Drivers
  3. 2.3 DNA and Gene Cloning Services Industry Opportunities and Challenges
  4. 2.4 DNA and Gene Cloning Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global DNA and Gene Cloning Services Market Perspective (2021-2032)
  2. 3.2 Global DNA and Gene Cloning Services Growth Trends by Region
  3. 3.2.1 Global DNA and Gene Cloning Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA and Gene Cloning Services Market Size by Region (2021-2026)
  5. 3.2.3 Global DNA and Gene Cloning Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global DNA and Gene Cloning Services Revenue by Players
  2. 4.1.1 Global DNA and Gene Cloning Services Revenue by Players (2021-2026)
  3. 4.1.2 Global DNA and Gene Cloning Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global DNA and Gene Cloning Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA and Gene Cloning Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global DNA and Gene Cloning Services Key Players Headquarters & Area Served
  7. 4.4 Global DNA and Gene Cloning Services Players, Product Type & Application
  8. 4.5 Global DNA and Gene Cloning Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global DNA and Gene Cloning Services Market CR5 and HHI
  11. 4.6.3 2025 DNA and Gene Cloning Services Tier 1, Tier 2, and Tier 3
5 DNA and Gene Cloning Services Market Size by Type
  1. 5.1 Global DNA and Gene Cloning Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global DNA and Gene Cloning Services Revenue by Type (2021-2032)
  3. 5.3 Global DNA and Gene Cloning Services Revenue Market Share by Type (2021-2032)
6 DNA and Gene Cloning Services Market Size by Application
  1. 6.1 Global DNA and Gene Cloning Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global DNA and Gene Cloning Services Revenue by Application (2021-2032)
  3. 6.3 Global DNA and Gene Cloning Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aragen Life Sciences
  2. 7.1.1 Aragen Life Sciences Company Information
  3. 7.1.2 Aragen Life Sciences Business Overview
  4. 7.1.3 Aragen Life Sciences DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aragen Life Sciences DNA and Gene Cloning Services Product Portfolio
  6. 7.1.5 Aragen Life Sciences Recent Developments
  7. 7.2 Bio-Techne
  8. 7.2.1 Bio-Techne Company Information
  9. 7.2.2 Bio-Techne Business Overview
  10. 7.2.3 Bio-Techne DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bio-Techne DNA and Gene Cloning Services Product Portfolio
  12. 7.2.5 Bio-Techne Recent Developments
  13. 7.3 Charles River Laboratories
  14. 7.3.1 Charles River Laboratories Company Information
  15. 7.3.2 Charles River Laboratories Business Overview
  16. 7.3.3 Charles River Laboratories DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Charles River Laboratories DNA and Gene Cloning Services Product Portfolio
  18. 7.3.5 Charles River Laboratories Recent Developments
  19. 7.4 Curia
  20. 7.4.1 Curia Company Information
  21. 7.4.2 Curia Business Overview
  22. 7.4.3 Curia DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Curia DNA and Gene Cloning Services Product Portfolio
  24. 7.4.5 Curia Recent Developments
  25. 7.5 Eurofins
  26. 7.5.1 Eurofins Company Information
  27. 7.5.2 Eurofins Business Overview
  28. 7.5.3 Eurofins DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins DNA and Gene Cloning Services Product Portfolio
  30. 7.5.5 Eurofins Recent Developments
  31. 7.6 GenScript
  32. 7.6.1 GenScript Company Information
  33. 7.6.2 GenScript Business Overview
  34. 7.6.3 GenScript DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GenScript DNA and Gene Cloning Services Product Portfolio
  36. 7.6.5 GenScript Recent Developments
  37. 7.7 Integrated DNA Technologies
  38. 7.7.1 Integrated DNA Technologies Company Information
  39. 7.7.2 Integrated DNA Technologies Business Overview
  40. 7.7.3 Integrated DNA Technologies DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Integrated DNA Technologies DNA and Gene Cloning Services Product Portfolio
  42. 7.7.5 Integrated DNA Technologies Recent Developments
  43. 7.8 MedGenome
  44. 7.8.1 MedGenome Company Information
  45. 7.8.2 MedGenome Business Overview
  46. 7.8.3 MedGenome DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MedGenome DNA and Gene Cloning Services Product Portfolio
  48. 7.8.5 MedGenome Recent Developments
  49. 7.9 Sino Biological
  50. 7.9.1 Sino Biological Company Information
  51. 7.9.2 Sino Biological Business Overview
  52. 7.9.3 Sino Biological DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sino Biological DNA and Gene Cloning Services Product Portfolio
  54. 7.9.5 Sino Biological Recent Developments
  55. 7.10 Syngene
  56. 7.10.1 Syngene Company Information
  57. 7.10.2 Syngene Business Overview
  58. 7.10.3 Syngene DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Syngene DNA and Gene Cloning Services Product Portfolio
  60. 7.10.5 Syngene Recent Developments
  61. 7.11 Twist Bioscience
  62. 7.11.1 Twist Bioscience Company Information
  63. 7.11.2 Twist Bioscience Business Overview
  64. 7.11.3 Twist Bioscience DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Twist Bioscience DNA and Gene Cloning Services Product Portfolio
  66. 7.11.5 Twist Bioscience Recent Developments
8 North America
  1. 8.1 North America DNA and Gene Cloning Services Revenue (2021-2032)
  2. 8.2 North America DNA and Gene Cloning Services Revenue by Type (2021-2032)
  3. 8.2.1 North America DNA and Gene Cloning Services Revenue by Type (2021-2026)
  4. 8.2.2 North America DNA and Gene Cloning Services Revenue by Type (2027-2032)
  5. 8.3 North America DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
  6. 8.4 North America DNA and Gene Cloning Services Revenue by Application (2021-2032)
  7. 8.4.1 North America DNA and Gene Cloning Services Revenue by Application (2021-2026)
  8. 8.4.2 North America DNA and Gene Cloning Services Revenue by Application (2027-2032)
  9. 8.5 North America DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
  10. 8.6 North America DNA and Gene Cloning Services Revenue by Country
  11. 8.6.1 North America DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America DNA and Gene Cloning Services Revenue by Country (2021-2026)
  13. 8.6.3 North America DNA and Gene Cloning Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe DNA and Gene Cloning Services Revenue (2021-2032)
  2. 9.2 Europe DNA and Gene Cloning Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe DNA and Gene Cloning Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe DNA and Gene Cloning Services Revenue by Type (2027-2032)
  5. 9.3 Europe DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe DNA and Gene Cloning Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe DNA and Gene Cloning Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe DNA and Gene Cloning Services Revenue by Application (2027-2032)
  9. 9.5 Europe DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe DNA and Gene Cloning Services Revenue by Country
  11. 9.6.1 Europe DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe DNA and Gene Cloning Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe DNA and Gene Cloning Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China DNA and Gene Cloning Services Revenue (2021-2032)
  2. 10.2 China DNA and Gene Cloning Services Revenue by Type (2021-2032)
  3. 10.2.1 China DNA and Gene Cloning Services Revenue by Type (2021-2026)
  4. 10.2.2 China DNA and Gene Cloning Services Revenue by Type (2027-2032)
  5. 10.3 China DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
  6. 10.4 China DNA and Gene Cloning Services Revenue by Application (2021-2032)
  7. 10.4.1 China DNA and Gene Cloning Services Revenue by Application (2021-2026)
  8. 10.4.2 China DNA and Gene Cloning Services Revenue by Application (2027-2032)
  9. 10.5 China DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA and Gene Cloning Services Revenue (2021-2032)
  2. 11.2 Asia DNA and Gene Cloning Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia DNA and Gene Cloning Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia DNA and Gene Cloning Services Revenue by Type (2027-2032)
  5. 11.3 Asia DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia DNA and Gene Cloning Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia DNA and Gene Cloning Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia DNA and Gene Cloning Services Revenue by Application (2027-2032)
  9. 11.5 Asia DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia DNA and Gene Cloning Services Revenue by Country
  11. 11.6.1 Asia DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia DNA and Gene Cloning Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia DNA and Gene Cloning Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA and Gene Cloning Services Revenue (2021-2032)
  2. 12.2 SAMEA DNA and Gene Cloning Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA DNA and Gene Cloning Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA DNA and Gene Cloning Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA DNA and Gene Cloning Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA DNA and Gene Cloning Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA DNA and Gene Cloning Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA DNA and Gene Cloning Services Revenue by Country
  11. 12.6.1 SAMEA DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA DNA and Gene Cloning Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA DNA and Gene Cloning Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst